相关实验视频

Updated: Jul 15, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

在瘤免疫调节和免疫治疗中重新编程树突细胞的脂质代谢

Zhanbo Sun¹, Lingyun Zhang², Lixian Liu³

¹Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|September 27, 2023

概括

树突细胞 (DCs) 是关键的免疫细胞,其脂质代谢影响T细胞反应. 重编程DC脂质代谢为增强癌症免疫疗法和抗瘤疗法提供了有希望的策略.

科学领域:

免疫学免疫学免疫学
细胞的新陈代谢
癌症治疗癌症治疗

背景情况:

树突细胞 (DCs) 是强大的抗原呈现细胞,对于弥合先天性和适应性免疫至关重要.
细胞代谢,特别是脂质代谢,显著影响DC激活,功能和生存.
新出现的证据强调了脂质代谢在调节DC介导免疫反应中的作用.

研究的目的:

审查树突细胞的生理性脂质代谢.
在瘤免疫调节的背景下分析DC脂质代谢的重编程.
讨论针对癌症治疗的DC脂质代谢的潜在免疫治疗策略.

主要方法:

关于树突细胞生物学和脂质代谢研究的文献综述.
分析研究,将脂质代谢重编程与瘤中的免疫反应联系起来.
综合当前关于免疫治疗方法的知识,涉及树突细胞.

主要成果:

脂质代谢与树突细胞激活和免疫功能密切相关.
在DC中改变脂质代谢可以调节抗瘤免疫力.
准DC脂质代谢显示出增强免疫疗法疗效的潜力.

结论:

了解树突细胞脂质代谢对于推进癌症免疫治疗至关重要.
在DC中重新编程脂质代谢是改善抗瘤疗法的有希望的策略.
这种方法有可能克服目前基于树突细胞的癌症治疗的局限性.

关键词:

树状细胞树状细胞免疫治疗是一种免疫疗法.脂质新陈代谢脂质新陈代谢瘤免疫调节瘤免疫调节瘤微环境是一个微环境.

更多相关视频

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.